News

2011 Annual Meeting of the Radiological Society of North America: Advances in imaging aid detection of cancer

The following reports are based on presentations at the 2011 annual meeting of the Radiological Society of North America, held November 27–December 2, 2011, in Chicago.


 

Family history data support annual mammograms in 40s

Women aged 40–49 years with and without a family history of breast cancer had almost the same rates of invasive disease in a retrospective analysis of data on more than 1,000 patients diagnosed over a 10-year period at a single site.

The finding adds weight to the American Cancer Society’s recommendation in favor of annual screening mammograms for women beginning at age 40, said principal author Dr. Stamatia V. Destounis of Elizabeth Wende Breast Care LLC in Rochester, NY. Dr. Destounis presented the results of her study in a press briefing.

A study presented at last year’s meeting by researchers at the London Breast Institute of the Princess Grace Hospital indicated that annual mammograms could reduce by half the risk of mastectomy in women who were diagnosed with breast cancer between the ages of 40 and 50 years.

Both studies challenge the recommendation against routine annual mammography for women under the age of 50 made in 2009 by the US Preventive Services Task Force. ...

* For a PDF of the full article, click in the link to the left of this introduction.

Recommended Reading

Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
MDedge Hematology and Oncology
Coordination of Care in Breast Cancer Survivors: An Overview
MDedge Hematology and Oncology
Older Women Shortchanged on Gains in Breast Cancer Survival
MDedge Hematology and Oncology
Diversity of Triple-Negative Breast Cancer Complicates Treatment
MDedge Hematology and Oncology
Walking Ability Aids Assessment of Elderly Breast Cancer Patients
MDedge Hematology and Oncology
FDA Revokes Avastin Approval for Breast Cancer
MDedge Hematology and Oncology
Have Your Say on the Avastin Decision
MDedge Hematology and Oncology
Medicare Won't Change Avastin Coverage For Now
MDedge Hematology and Oncology
Mammography: Family History Data Support Yearly Screening
MDedge Hematology and Oncology
Community Oncology Podcast: Everolimus in ER-positive breast cancer
MDedge Hematology and Oncology